Biocon Biologics
Healthcare
Flashback 2025: Healthcare dealmaking stays strong as hospitals, other segments draw interest
India's healthcare sector continued to see strong dealmaking activity this year, with private equity players paying top dollar for sub-sectors ......
Healthcare
True North, Tata Capital's growth PE fund stare at poor outcome from exit window
Private equity firm True North and Tata Capital Growth Fund are getting an exit window for the future from a ......
Healthcare
Edelweiss Alts gets a quick exit window from healthcare bet
The Mumbai-based Edelweiss Group’s alternative investment arm is set to score an exit from a healthcare bet it made just ......
Manufacturing
Kotak Alts looks to invest in South India-based manufacturing firm
Kotak Alternate Asset Managers Ltd, the alternative asset management arm of the Kotak Mahindra Group, is in talks to invest ......
Healthcare
Abu Dhabi wealth fund ADQ signing off from India bet with a bummer
Abu Dhabi sovereign wealth fund ADQ has pressed the sell button on one of its handful of private equity-style investments ......
General
Grapevine: Temasek nears VFS stake deal; LG Electronics taps banks for India IPO
Temasek Holdings Pte is nearing a deal to acquire a significant minority stake in VFS Global, valuing the visa outsourcing firm at ......
Healthcare
Exclusive: Biocon weighs fresh funding for PE-backed biosimilars unit
Biocon Ltd is looking to raise fresh funding for its biosimilars unit that has previously secured capital from five private ......
General
Grapevine: Actis may trim Profectus stake; Goldman to double down on MoEngage
Private equity firm Actis is looking to sell a stake in Profectus Capital, a non-banking finance company that it fully ......
Healthcare
Eris Lifesciences acquires two businesses from Biocon arm
Eris Lifesciences Ltd, a Mumbai-listed pharmaceutical company backed by private equity firm ChrysCapital and Kuwait Investment Authority, has agreed to purchase ......
Healthcare
Biocon may list biosimilars business by 2025 first half: CEO
Indian biopharmaceutical company Biocon Ltd is planning to list its biosimilars business, a significant contributor to the company's total revenue, ......
Most Popular
Google News
Follow VCCircle on Google News for the latest updates on Business and Startup News